Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
SEC injury reports reveal key absences for top teams ahead of crucial matchups.
Pentagon approves Tomahawk missiles for Ukraine, but Trump delays delivery amid concerns over U.S. defense capabilities and Russia's warnings.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
SEC injury reports reveal key absences for top teams ahead of crucial matchups.
Pentagon approves Tomahawk missiles for Ukraine, but Trump delays delivery amid concerns over U.S. defense capabilities and Russia's warnings.